Bodenstedt Matthias sold MLTX
April 14, 2026 · Form 4 insider transaction
Bodenstedt Matthias sold 2,426 shares of MoonLake Immunotherapeutics at $19.56 per share, a transaction worth $47.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.; The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $19.500 to $19.625. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.